Tucson biotech seeks $20M in IPO as oxygen therapeutic wins FDA fast track

The Tucson company will use its IPO proceeds to advance trials for NanO2, designed to treat hypoxia after stroke. It would be ...

Scientists Were Wrong About Fireflies’s Light. The Impact Could Ripple Across All of Science.

For more than a century, an overestimation of a firefly’s brightness has persisted.
Local News Matters on MSN

Clear Lake is not so clear these days

Pull up the satellite map from the San Francisco Estuary Institute, and it colors each lake by how much cyanobacteria the ...